What is the current size and annual growth rate of the dermatological drugs market?
The dermatological drugs market size has grown strongly in recent years. It will grow from $20.06 billion in 2024 to $22.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of skin disorders, advancements in drug formulation and delivery, increasing awareness about skincare and aesthetics, expansion of the aging population, growing demand for over-the-counter dermatological products.
The dermatological drugs market size is expected to see strong growth in the next few years. It will grow to $31.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to advancements in biologics and targeted therapies, growing adoption of teledermatology and digital health, increasing prevalence of lifestyle-related skin conditions, rising demand for personalized and regenerative medicine, expanding research in microbiome-based dermatological treatments. Major trends in the forecast period include nanotechnology-based drug delivery, ai-driven dermatological diagnostics, microbiome-targeted therapies, 3d bioprinting for skin regeneration, gene editing and rna-based treatments.
Get Your Free Sample of The Global Dermatological Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21166&type=smp
Which major factors have contributed to the expansion of the dermatological drugs market?
The rising demand for cosmetic dermatology procedures is expected to propel the growth of the dermatological drugs market going forward. Cosmetic dermatology is a specialized branch of dermatology that focuses on enhancing a person’s appearance through various non-surgical treatments and procedures. The demand for cosmetic dermatology is on the rise due to increasing consumer awareness of aesthetic treatments, advancements in skincare technology, and a growing preference for non-invasive procedures to enhance appearance and combat aging. The growing demand for cosmetic dermatology procedures, such as anti-aging and skin rejuvenation treatments, is driving the development of advanced dermatological drugs that offer safe, effective, and minimally invasive solutions. For instance, in January 2023, according to the international Society of Aesthetic Plastic Surgery, a US-based professional organization, over 12.8 million surgical and 17.5 million non-surgical operations were conducted globally, representing a 19.3% rise in total procedures from the previous reporting period. Additionally, more than 14.9 million surgical and 18.8 million non-surgical operations will be carried out globally by plastic surgeons in 2022, representing an 11.2% rise in total procedures performed. Therefore, the rising cosmetic dermatology procedures is driving the growth of the dermatological drugs market.
How is the dermatological drugs market segmented?
The dermatological drugs market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Retinoids, Antibiotics, Antifungals, Calcineurin Inhibitors, Other Drug Classes
2) By Administration: Topical Administration, Oral Administration, Parenteral Administration
3) By Indication: Acne, Psoriasis, Rosacea, Alopecia, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Retinoids: Topical Retinoids, Oral Retinoids
3) By Antibiotics: Topical Antibiotics, Oral Antibiotics
4) By Antifungals: Topical Antifungals, Oral Antifungals
5) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors, Systemic Calcineurin Inhibitors
6) By Other Drug Classes: Biologics, JAK Inhibitors, Antihistamines, Photodynamic Therapy Agents
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/dermatological-drugs-global-market-report
Who are the top competitors in the dermatological drugs market?
Major companies operating in the dermatological drugs market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Bausch Health Companies Inc., Organon International, Galderma, Incyte Corporation, Glenmark Pharmaceuticals Ltd., Mayne Pharma Group Limited, Dermavant Sciences Inc., Taro Pharmaceutical Industries Ltd., Biofrontera AG, Almirall SA, UCB SA, LEO Pharma A/S, Dermira Inc.
Which key trends are expected to influence the dermatological drugs market in the coming years?
Major companies operating in the dermatological drugs market are prioritizing the development of biologic treatments to address chronic skin conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. Biologics target specific immune pathways, offering more effective and long-lasting relief compared to traditional therapies. For instance, in September 2024, Eli Lilly and Company, a US-based pharmaceutical company, received approval for Ebglyss (lebrikizumab), a targeted interleukin-13 (IL-13) inhibitor, for treating moderate-to-severe atopic dermatitis in adults and children aged 12 and older. This approval marks a significant advancement by offering a new biologic treatment option for patients who have not achieved adequate symptom control with topical therapies. Addressing the need for more effective treatments, Ebglyss aims to improve patients’ quality of life by reducing severe itching and skin inflammation associated with moderate-to-severe atopic dermatitis.
Which regional trends are influencing the dermatological drugs market, and which area dominates the industry?
North America was the largest region in the dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Dermatological Drugs Market Report 2025 Offer?
The dermatological drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Dermatological drugs refer to medications designed to treat conditions affecting the skin, hair, and nails by reducing inflammation, controlling infections, or managing symptoms such as itching and redness. These drugs play a crucial role in dermatology by addressing both common and severe skin disorders, improving patient comfort and quality of life.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21166
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
